These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1516893)

  • 1. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in overweight women.
    Ritter MM; Richter WO; Schwandt P
    Horm Metab Res; 1992 Jul; 24(7):349-50. PubMed ID: 1516893
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in normal-weight men.
    Ritter MM; Richter WO; Schwandt P
    Horm Metab Res; 1989 Jul; 21(7):383-6. PubMed ID: 2528500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pro-opiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose.
    Knudtzon J
    Horm Metab Res; 1986 Sep; 18(9):579-83. PubMed ID: 3023222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new beta cell efficiency test in the islands of Langerhans].
    Páv J; Srámková J
    Vnitr Lek; 1977 Jun; 23(7):639-46. PubMed ID: 331663
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No change of beta-endorphin plasma levels during hyperglycemic glucose clamping in obese patients and lean controls.
    Ritter MM; Möhrle W; Richter WO; Schwandt P
    Horm Metab Res; 1990 Sep; 22(9):504-5. PubMed ID: 2258138
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration.
    Baptista T; Lacruz A; Angeles F; Silvera R; de Mendoza S; Mendoza MT; Hernández L
    Pharmacopsychiatry; 2001 Nov; 34(6):223-31. PubMed ID: 11778142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss.
    Giovannini C; Ciucci E; Clementi R; Cugini P; Facchinetti F; Negri M
    Horm Metab Res; 1990 Feb; 22(2):96-100. PubMed ID: 2157655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
    Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
    Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose suppression of glucagon: relationship to pancreatic beta cell function?
    Hatfield HH; Banasiak MF; Driscoll T; Kim HJ; Kalkhoff RK
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1080-7. PubMed ID: 326805
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of vertical banded gastroplasty on glucose-induced beta-endorphin response.
    Karayiannakis AJ; Syrigos KN; Zbar A; Makri GG; Athanasiadis L; Alexiou D; Bastounis EA
    J Surg Res; 1998 Dec; 80(2):123-8. PubMed ID: 9878302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Responses of alpha and beta cells of the pancreas to arginine during cardiopulmonary bypass].
    Hamaji M; Miyata M; Hirose H; Nakao K; Kawashima Y
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Sep; 31(9):1344-51. PubMed ID: 6366085
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells.
    Kavelaars A; Ballieux RE; Heijnen CJ
    J Immunol; 1989 Apr; 142(7):2338-42. PubMed ID: 2522482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (CRF).
    Almeida OF; Nikolarakis KE; Herz A
    NIDA Res Monogr; 1986; 75():401-2. PubMed ID: 2893273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma insulin and glucagon responses to isoglycemic stimulation in normal pregnancy and post partum.
    Hornnes PJ; Kuhl C
    Obstet Gynecol; 1980 Apr; 55(4):425-7. PubMed ID: 6988747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure.
    Barreca T; Robaudo C; Cataldi A; Garibaldi A; Cianciosi P; Russo R; Rolandi E; Franceschini R
    Biomed Pharmacother; 1995; 49(6):283-7. PubMed ID: 7579009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone (CRH) produces analgesia in a thermal injury model independent of its effect on systemic beta-endorphin and corticosterone.
    Cepeda MS; Bonney I; Weiss JM; Moyano J; Carr DB
    Regul Pept; 2004 Apr; 118(1-2):39-43. PubMed ID: 14759555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-endorphin and obesity. Possible pathogenetic implications].
    Giugliano D; Saccomanno F; Quatraro A; Ceriello A; Torella R
    Minerva Endocrinol; 1990; 15(2):149-51. PubMed ID: 2098658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma beta-endorphin levels in obese and non-obese patients with polycystic ovary disease.
    Martínez-Guisasola J; Guerrero M; Alonso F; Díaz F; Cordero J; Ferrer J
    Gynecol Endocrinol; 2001 Feb; 15(1):14-22. PubMed ID: 11293919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.